First Republic Investment Management, Inc. Meridian Bioscience Inc Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$31.15 - $33.39 $26,975 - $28,915	-866 Reduced 2.32%	36,397 $1.21 Million
Q3 2022 Nov 03, 2022	SELL	$30.9 - $33.55 $139,050 - $150,975	-4,500 Reduced 10.78%	37,263 $1.18 Million
Q2 2022 Aug 16, 2022	BUY	$23.75 - $31.69 $21,636 - $28,869	911 Added 2.23%	41,763 $1.27 Million
Q1 2022 May 16, 2022	SELL	$19.97 - $26.94 $58,472 - $78,880	-2,928 Reduced 6.69%	40,852 $1.06 Million
Q4 2021 Feb 09, 2022	SELL	$17.46 - $21.61 $7,734 - $9,573	-443 Reduced 1.0%	43,780 $893,000
Q3 2021 Nov 12, 2021	BUY	$17.35 - $22.5 $72,037 - $93,420	4,152 Added 10.36%	44,223 $851,000
Q2 2021 Aug 16, 2021	BUY	$18.01 - $28.32 $93,345 - $146,782	5,183 Added 14.86%	40,071 $889,000
Q1 2021 May 14, 2021	SELL	$19.76 - $29.89 $18,040 - $27,289	-913 Reduced 2.55%	34,888 $916,000
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $26,599 - $36,627	1,691 Added 4.96%	35,801 $669,000
Q3 2020 Nov 12, 2020	SELL	$13.54 - $26.41 $71,382 - $139,233	-5,272 Reduced 13.39%	34,110 $579,000
Q2 2020 Aug 13, 2020	BUY	$7.84 - $23.29 $132,292 - $392,995	16,874 Added 74.97%	39,382 $917,000
Q1 2020 May 13, 2020	BUY	$5.57 - $11.5 $58,323 - $120,416	10,471 Added 86.99%	22,508 $189,000
Q4 2019 Feb 14, 2020	BUY	$7.9 - $10.14 $4,266 - $5,475	540 Added 4.7%	12,037 $118,000
Q3 2019 Nov 08, 2019	BUY	$9.17 - $12.01 $5,685 - $7,446	620 Added 5.7%	11,497 $109,000
Q2 2019 Aug 07, 2019	SELL	$10.88 - $17.6 $772 - $1,249	-71 Reduced 0.65%	10,877 $129,000
Q1 2019 Apr 30, 2019	SELL	$15.51 - $17.61 $120,450 - $136,759	-7,766 Reduced 41.5%	10,948 $193,000
Q4 2018 Feb 12, 2019	BUY	$14.52 - $19.72 $3,978 - $5,403	274 Added 1.49%	18,714 $325,000
Q3 2018 Nov 13, 2018	BUY	$14.85 - $16.35 $37,095 - $40,842	2,498 Added 15.67%	18,440 $275,000
Q2 2018 Aug 14, 2018	BUY	$13.8 - $16.8 $7,424 - $9,038	538 Added 3.49%	15,942 $254,000
Q1 2018 May 10, 2018	BUY	$13.8 - $16.2 $39,261 - $46,089	2,845 Added 22.65%	15,404 $218,000
Q4 2017 Feb 09, 2018	BUY	$13.55 - $15.8 $15,419 - $17,980	1,138 Added 9.96%	12,559 $176,000
Q3 2017 Nov 14, 2017	BUY	$13.45 - $14.35 $153,612 - $163,891	11,421	11,421 $163,000

Others Institutions Holding VIVO

# of Institutions

Shares Held

113K

Call Options Held

Put Options Held

View Full List

About MERIDIAN BIOSCIENCE INC

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

More about VIVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account